Data And More Data Expected To Drive BTG Towards Triple-Growth Target
This article was originally published in Clinica
Interventional medicine specialist BTG plc has set its sights high. Its largest franchise, interventional oncology, reported sales of £75.5m ($112m) for fiscal 2015 and the UK company is aiming to at least triple this figure to $300-400m by 2021. With 2016 already upon us, time is ticking by.
Register for our free email digests: